Literature DB >> 24133257

Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation.

Aaron Kucinski1, Giovanna Paolone, Marc Bradshaw, Roger L Albin, Martin Sarter.   

Abstract

Cognitive symptoms, complex movement deficits, and increased propensity for falls are interrelated and levodopa-unresponsive symptoms in patients with Parkinson's disease (PD). We developed a test system for the assessment of fall propensity in rats and tested the hypothesis that interactions between loss of cortical cholinergic and striatal dopaminergic afferents increase fall propensity. Rats were trained to traverse stationary and rotating rods, placed horizontally or at inclines, and while exposed to distractors. Rats also performed an operant Sustained Attention Task (SAT). Partial cortical cholinergic and/or caudate dopaminergic deafferentation were produced by bilateral infusions of 192 IgG-saporin (SAP) into the basal forebrain and/or 6-hydroxydopamine (6-OHDA) into the caudate nucleus, respectively, modeling the lesions seen in early PD. Rats with dual cholinergic-dopaminergic lesions (DL) fell more frequently than SAP or 6-OHDA rats. Falls in DL rats were associated with incomplete rebalancing after slips and low traversal speed. Ladder rung walking and pasta handling performance did not indicate sensorimotor deficits. SAT performance was impaired in DL and SAP rats; however, SAT performance and falls were correlated only in DL rats. Furthermore, in DL rats, but not in rats with only dopaminergic lesions, the placement and size of dopaminergic lesion correlated significantly with fall rates. The results support the hypothesis that after dual cholinergic-dopaminergic lesions, attentional resources can no longer be recruited to compensate for diminished striatal control of complex movement, thereby "unmasking" impaired striatal control of complex movements and yielding falls.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24133257      PMCID: PMC6618519          DOI: 10.1523/JNEUROSCI.2545-13.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  31 in total

1.  Complex Movement Control in a Rat Model of Parkinsonian Falls: Bidirectional Control by Striatal Cholinergic Interneurons.

Authors:  Cassandra Avila; Aaron Kucinski; Martin Sarter
Journal:  J Neurosci       Date:  2020-06-18       Impact factor: 6.167

Review 2.  Cholinergic double duty: cue detection and attentional control.

Authors:  Martin Sarter; Cindy Lustig
Journal:  Curr Opin Psychol       Date:  2019-01-04

3.  Cholinergic nucleus 4 atrophy and gait impairment in Parkinson's disease.

Authors:  W Alex Dalrymple; Diane S Huss; Jamie Blair; Joseph L Flanigan; James Patrie; Scott A Sperling; Binit B Shah; Madaline B Harrison; T Jason Druzgal; Matthew J Barrett
Journal:  J Neurol       Date:  2020-07-28       Impact factor: 4.849

4.  Cortical Implications of Advancing Age and Disease Duration in Parkinson's Disease Patients with Postural Instability and Gait Dysfunction.

Authors:  Joshua N Herb; Swati Rane; David A Isaacs; Nelleke Van Wouwe; Olivia C Roman; Bennett A Landman; Benoit M Dawant; Peter Hedera; David H Zald; Joseph S Neimat; Scott A Wylie; Manus J Donahue; Daniel O Claassen
Journal:  J Parkinsons Dis       Date:  2016-05-05       Impact factor: 5.568

Review 5.  Molecular Imaging of the Cholinergic System in Parkinson's Disease.

Authors:  Nicolaas I Bohnen; Prabesh Kanel; Martijn L T M Müller
Journal:  Int Rev Neurobiol       Date:  2018-09-20       Impact factor: 3.230

Review 6.  Freezing of gait: understanding the complexity of an enigmatic phenomenon.

Authors:  Daniel Weiss; Anna Schoellmann; Michael D Fox; Nicolaas I Bohnen; Stewart A Factor; Alice Nieuwboer; Mark Hallett; Simon J G Lewis
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

7.  Cholinergic capacity mediates prefrontal engagement during challenges to attention: evidence from imaging genetics.

Authors:  Anne S Berry; Randy D Blakely; Martin Sarter; Cindy Lustig
Journal:  Neuroimage       Date:  2014-12-20       Impact factor: 6.556

8.  Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease.

Authors:  Ajeesh Koshy Cherian; Aaron Kucinski; Ryan Wu; Inge E M de Jong; Martin Sarter
Journal:  Psychopharmacology (Berl)       Date:  2019-01-04       Impact factor: 4.530

Review 9.  Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.

Authors:  Martin Sarter; Roger L Albin; Aaron Kucinski; Cindy Lustig
Journal:  Exp Neurol       Date:  2014-05-05       Impact factor: 5.330

Review 10.  Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline.

Authors:  Elizabeth C Ballinger; Mala Ananth; David A Talmage; Lorna W Role
Journal:  Neuron       Date:  2016-09-21       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.